The FDA has decided to allow dispensing of mifepristone from Danco Laboratories by mail using certified prescribers of pharmacies. The move also allows dispensing of the drug via telemedicine.
The agency had previously required that individuals obtain the abortion drug mifepristone (Mifeprex) in person.
FDA notes that the mail-order distribution model became popular during the pandemic, leading the agency to cease enforcing the in-person dispensing rule.
Some states, however, have moved to block the distribution of the drug, which is also known as RU486.
FDA indicates that the progestin antagonist mifepristone be used together with the drug misoprostol in the first 70 days of gestation. Misoprostol is a widely available prescription drug indicated as an ulcer treatment. FDA recommends that patients take mifepristone first and then misoprostol two days later.
Nearly half of U.S. states have either banned or limited the use of the mifepristone-misoprostol cocktail.
Demand for abortion pills has jumped recently as the Supreme Court considers the future of Roe v. Wade, according to Bloomberg Law.
Hello I need advice, Im 4 months pregnant when I took mifepristone 200 mg on 28th April but I didnt take the second pill which is the misprostol because I want to pursue my pregnancy. I cant sleep im bothered until now, does mife 200 mg can cause birth defects or any problems when I born my baby?
Please help, thankyou!
Hi Janice,
This UK site found there are “insufficient data to determine if mifepristone exposure in monotherapy is associated with an increased risk of congenital malformation in the fetus.”
It also concluded that “additional fetal monitoring may be warranted for ongoing pregnancies” just to be sure.
A 2013 study concluded that the data were “reassuring” for continuation of pregnancy after mifepristone exposure.
Please follow up with a physician.
Best wishes,
Brian